‘Motivated by greed’: Influential businessman jailed for smuggling drugs into New Zealand deported to Fiji
Aiyaz Mohammed Musa Umarji, 48, pleaded guilty to importing $5 million of pseudoephedrine - a key ingredient to manufacture ...
Next-gen weight loss drugs will have fewer side effects than Ozempic, pharma CEO says
Zealand Pharma CEO Adam Steensberg said Friday that the company is working on a next-generation weight loss drug that’s ...
Can this European biotech challenge Eli Lilly in the booming weight-loss market?
Zealand Pharma is working on the next-gen weight-loss treatment. Its Petrelintide showed promising results in a Phase 1b ...
Novo and Lilly contender Zealand Pharma heralds its obesity drug alternative: It's our 'crown jewel'
Danish biotech Zealand Pharma is targeting the "next generation" of weight loss drugs as competitors pile into a market ...
Zealand Pharma targeting 'next generation' of obesity drugs, CEO says
Zealand Pharma's CEO Adam Steensberg weighs in on early-stage trials of its obesity drug contender and talks down takeover ...
European markets expected to open slightly higher; UK GDP data in focus
European markets are expected to open slightly higher on Friday as investors look ahead to highly anticipated fiscal stimulus ...
Investing1d
New Zealand dollar has further to fall - UBS
Investing.com - The New Zealand dollar fell after the Reserve Bank of New Zealand cut interest rates earlier this week, and ...
The Pharma Letter1d
FDA slaps another CRL on Zealand Pharma’s dasiglucagon NDA
The US Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) for Part 1 of the New Drug Application ...
Type 1 Diabetes Market Set To Eyewitness Substantial Growth By 2024-2031: Sanofi, Wockhardt Ltd., Ypsomed AG, Novartis
Type 1 Diabetes Market Set To Eyewitness Substantial Growth By 2024-2031: Sanofi, Wockhardt Ltd., Ypsomed AG, Novartis Type 1 Diabetes Market is expected to reach USD 24.36 Bn by 2031, exhibiting a ...
Pharmaceutical Technology1d
Boehringer and Circle Pharma link to develop new cancer treatment
Boehringer Ingelheim and Circle Pharma have signed a partnership and licence agreement focused on developing a new cancer ...
Zealand Pharma A/S (OTCMKTS:ZLDPF) Trading Down 2.3% – Here’s What Happened
Zealand Pharma A/S (OTCMKTS:ZLDPF – Get Free Report) traded down 2.3% during trading on Wednesday . The stock traded as low as $115.00 and last traded at $115.00. 505 shares traded hands during ...